persodia research
ivd industry, structured

Structural Analysis Repository

Persodia Research is an independent repository of structural analysis on the in-vitro diagnostics industry, publishing monographs, essays, tools, notes, and related analytical resources as the work develops.

4 items

Book Published

Inside Clinical Diagnostics Industry

Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence examines the diagnostics industry as a system governed by enduring structural constraints. Rather than describing products, technologies, or individual company decisions in isolation, it identifies the underlying industrial conditions that determine how diagnostic technologies are developed, deployed, and adopted at scale. Published in February 2026, the book provides the analytical foundation from which Persodia Research was established.

Access February 2026 Miguel Oliveira
Monograph Published New

Earning Position: How Evidence Becomes Authority

Most diagnostics that fail to reach sustained clinical use do not fail analytically. The evidence exists. The performance is demonstrated. What is missing is alignment — across the domains that govern adoption, the actors that grant authority, and the timelines that determine whether evidence built before market entry reaches the practice it was designed to change. This monograph examines that structural condition, and what it takes for evidence to become position.

Evidence April 2026 Miguel Oliveira
Monograph Published New

Crossing from Analytical to Diagnostics

Most analytical technologies never reach clinical diagnostics — not because they lack performance, but because they are not built for the structural conditions clinical markets impose. This monograph examines what those conditions are, why they defeat most crossings, and what a complete crossing actually requires.

Infrastructure March 2026 Miguel Oliveira
Tool Published New

Crossing from Analytical to Diagnostics (tool)

The Crossing Assessment Tool evaluates how a product aligns with the structural conditions required for clinical diagnostics deployment. It makes visible what is already in place, what is being built with committed resources, and what remains absent — turning an otherwise opaque transition into a structured, comparable assessment.

Infrastructure March 2026 Miguel Oliveira

Readers are welcome to engage with the material, respond to it, and contribute relevant work for consideration. For context on the programme and editorial approach, please read About.